Back to search

Switzerland· 45866017

Phosphonorm, Hartkapseln

A aluminium chlorohydrate product containing aluminii chloridum/hydroxidum hydricum (9:8:19:23), registered in Switzerland by Salmon Pharma GmbH and dispensed under Swissmedic category B, on the national reimbursement list.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC M05BX02

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedPhosphonorm, HartkapselnATCM05BX02REGISTER NO.45866017PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Swissmedic (Switzerland)
Active substance
aluminii chloridum/hydroxidum hydricum (9:8:19:23)
Manufacturer
Salmon Pharma GmbH
Country
Switzerland (CH)
ATC code
M05BX02
ATC class
Aluminium chlorohydrate
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680458660174
    100 Stk
    CHF 51.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

13 interactions on record for aluminium chlorohydrate.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Aluminium chlorohydrate · interactions on record

13 records

13 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under M05BX02

Aluminium chlorohydrate, as other registers publish it.

All aluminium chlorohydrate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e5d8c942-b4aa-4df7-a4d5-d1c6449774d8
GET /v1/drugs/e5d8c942-b4aa-4df7-a4d5-d1c6449774d8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "aluminii chloridum/hydroxidum hydricum (9:8:19:23) 300 mg",
  "valid_from": "1987-03-15",
  "limitations": "[{\"description\":\"Nur bei nachgewiesener Anazidität.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2007-01-01\"}]",
  "galenic_form": "Kaps 300 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "1987-03-15",
  "self_retention_pct": 10
}

See everything about aluminium chlorohydrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.